Caldwell Sutter Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.57M Sell
6,405
-97
-1% -$22.6K 0.64% 38
2025
Q4
$1.35M Sell
6,502
-54
-0.8% -$10.7K 0.57% 43
2025
Q3
$1.22M Buy
6,556
+13
+0.2% +$2.23K 0.52% 47
2025
Q2
$999K Buy
6,543
+85
+1% +$13.1K 0.46% 55
2025
Q1
$1.07M Buy
6,458
+35
+0.5% +$5.48K 0.51% 50
2024
Q4
$929K Buy
6,423
+388
+6% +$60.1K 0.43% 59
2024
Q3
$978K Buy
6,035
+18
+0.3% +$2.87K 0.46% 56
2024
Q2
$879K Buy
6,017
+676
+13% +$101K 0.44% 63
2024
Q1
$845K Buy
5,341
+409
+8% +$65.1K 0.41% 69
2023
Q4
$773K Sell
4,932
-45
-0.9% -$6.9K 0.39% 70
2023
Q3
$775K Sell
4,977
-401
-7% -$66.2K 0.43% 66
2023
Q2
$890K Buy
5,378
+2,408
+81% +$389K 0.47% 63
2023
Q1
$460K Buy
2,970
+990
+50% +$160K 0.34% 75
2022
Q4
$350K Buy
+1,980
New +$342K 0.31% 72

Other funds holding JNJ

Caldwell Sutter Capital's JNJ Position: Q1 2026 in Review

Caldwell Sutter Capital reduced its Johnson & Johnson (JNJ) stake by 1.5% in Q1 2026, selling an estimated $22.6K and leaving 6,405 shares worth $1.57M. The position accounts for 0.64% of the portfolio, ranked #38.

Caldwell Sutter Capital first reported a position in JNJ in Q4 2022 and has held it in 14 quarters since. 4,617 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Caldwell Sutter Capital held 6,405 shares of Johnson & Johnson worth $1.57M as of Q1 2026.
  • Caldwell Sutter Capital sold 97 Johnson & Johnson shares in Q1 2026, an estimated $22.6K.
  • Johnson & Johnson made up 0.64% of Caldwell Sutter Capital's portfolio in Q1 2026, its #38 holding.
  • Caldwell Sutter Capital first reported a position in Johnson & Johnson in Q4 2022 and has held it in 14 quarters since.
  • 4,617 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Caldwell Sutter Capital's 13F filing for Q1 2026, filed 6 May 2026.